HLA-DQB1
HLA-DQB1geneHLA-DQB1 is a CAD susceptibility locus that influences inflammatory pathway activation in coronary atherothrombosis.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleHLA variants modulate immune activation in atherosclerotic plaque.
Druggability
DruggableNo
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableNo
EnsemblENSG00000179344
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I37
C — confounder / Type-II62
A — assay feasibility52
E — evidence strength23
T1DI (composite)5
Specificity differential (R−C)-24.6
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(2)
- Differential methylation pattern in patients with coronary artery disease: pilot study.Molecular biology reports · 2018 · PMID 30470965 · doi
- Genome-wide association study of coronary artery disease in the Japanese.European journal of human genetics : EJHG · 2011 · PMID 21971053 · doi